These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 17116051

  • 21. Choosing medical or surgical terminations of pregnancy in the first trimester: what is the difference?
    Goodyear-Smith F, Knowles A.
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):211-5. PubMed ID: 19432614
    [Abstract] [Full Text] [Related]

  • 22. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation.
    Hamoda H, Ashok PW, Flett GM, Templeton A.
    BJOG; 2004 Sep; 111(9):996-1000. PubMed ID: 15327616
    [Abstract] [Full Text] [Related]

  • 23. First trimester medical termination of pregnancy: an alternative for New Zealand women.
    Goodyear-Smith F, Knowles A, Masters J.
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):193-8. PubMed ID: 16704471
    [Abstract] [Full Text] [Related]

  • 24. Mifepristone and misoprostol for termination of early pregnancy.
    Randel J, French L.
    J Fam Pract; 1998 Aug; 47(2):96-7. PubMed ID: 9722793
    [Abstract] [Full Text] [Related]

  • 25. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
    Heikinheimo O, Leminen R, Suhonen S.
    Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H, Piaggio G, Wojdyla D, Marions L, My Huong NT, Tang OS, Fang AH, Wu SC, Kalmar L, Mittal S, Erdenetungalag R, Horga M, Pretnar-Darovec A, Kapamadzija A, Dickson K, Anh ND, Tai NV, Tuyet HT, Peregoudov A, WHO Research Group on Post-ovulatory Methods of Fertility Regulation.
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N, Borgatta L, Ellis SC, Stubblefield P.
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [Abstract] [Full Text] [Related]

  • 30. Misoprostol for termination of mid-trimester post-Caesarean pregnancy.
    Bhattacharjee N, Ganguly RP, Saha SP.
    Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):23-5. PubMed ID: 17261095
    [Abstract] [Full Text] [Related]

  • 31. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS, Creinin MD, Harwood B, Schreiber C.
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [Abstract] [Full Text] [Related]

  • 32. One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial.
    Mentula M, Suhonen S, Heikinheimo O.
    Hum Reprod; 2011 Oct; 26(10):2690-7. PubMed ID: 21798991
    [Abstract] [Full Text] [Related]

  • 33. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D, Deutsch M, Paz Y, Khatib N, Baltiter T, Rosenberg S, Lowenstein L.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [Abstract] [Full Text] [Related]

  • 34. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
    Väyrynen W, Heikinheimo O, Nuutila M.
    Acta Obstet Gynecol Scand; 2007 Jun; 86(6):701-5. PubMed ID: 17520402
    [Abstract] [Full Text] [Related]

  • 35. [Termination of 10-16 weeks's gestation with mifepristone plus misoprostol: a multicentre randomized clinical trial].
    Cheng L.
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):268-71. PubMed ID: 11326930
    [Abstract] [Full Text] [Related]

  • 36. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R, Rana A, Pradhan N.
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [Abstract] [Full Text] [Related]

  • 37. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N, Resche-Rigon M, Morin C, Ville Y, Rozenberg P.
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [Abstract] [Full Text] [Related]

  • 38. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
    Ebbers S, Creemers JW, Lotgering FK.
    Ned Tijdschr Geneeskd; 2009 Jul; 153():A138. PubMed ID: 19930731
    [Abstract] [Full Text] [Related]

  • 39. Misoprostol for second and third trimester termination of pregnancy: a review of practice at the Women's and Children's Hospital, Adelaide, Australia.
    Dodd J, O'Brien L, Coffey J.
    Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):25-9. PubMed ID: 15730361
    [Abstract] [Full Text] [Related]

  • 40. The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section.
    Daponte A, Nzewenga G, Dimopoulos KD, Guidozzi F.
    Contraception; 2006 Oct; 74(4):324-7. PubMed ID: 16982234
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.